Factors Associated with Medication Adherence among hypertensive Patients in a Tertiary Health Center: A Cross-Sectional Study
Article Sidebar
Main Article Content
Abstract
Introduction: Medication non-adherence is a major hindrance in the treatment of hypertension in Sub Saharan Africa. It is a major modifiable contributor to poor blood pressure control and complications of the disorder. An understanding of the factors that are associated with drug adherence in hypertension will contribute positively to the overall planning of public health educational programs on hypertension.
Methods: This study was cross sectional and descriptive in nature conducted in the medical outpatient clinic of Enugu State University Teaching Hospital, Enugu Nigeria. Data collection was done using a semi-structured questionnaire. The Morinsky-Green Medication adherence scale was used to estimate medication adherence. Statistical analyses was done using SPSS version 22 (IBM Corporation, New York, USA).
Results: A total of 436 patients were surveyed in this study. Most of the patients (90.1%) sometimes forget to take their medications or do not bring their medications along when they leave home (94.3%). The highest rates of non-adherence were reported in patients who were totally dependent (62.5%). High depression scores, low disability scores and the presence of peptic ulcer disease correlated with non-adherence. In regression analysis Morinsky-Green scores (R2 = 0.04), decreased by a factor of 0.06 with a unit increase in level of dependence, by a factor of 0.09 with a unit increase in HADS depression scores and by 0.73 in those that have peptic ulcer.
Conclusions:Non-adherence is high among hypertensive patients attending tertiary care centers in the South East. Educational measures targeted towards improving adherence are needed to reduce the level of non-adherence.
Downloads
Article Details
Copyright (c) 2017 Ezeala-Adikaibe BA, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Okwuonu CG, Ojimadu NE, Okaka EI, Akemokwe FM (2014) Patient-related barriers to hypertension control in a Nigerian population. Int J Gen Med 7: 345–353. Link: https://goo.gl/HNrRdh
Akpa MR., Agomuoh DI, Odia OJ (2005) Drug compliance among hypertensive patients in Port Harcourt, Nigeria. Nig J of Med 14: 55–57. Link: https://goo.gl/Z2NT37
Osamor PE, Owumi BE (2011) Factors associated with treatment compliance in hypertension in southwest Nigeria. J Health Popul Nutr 29: 619–628. Link: https://goo.gl/Zgm8WQ
Boima V, Ademola AD, Odusola AO, Agyekum F,Nwafor CE, et al. (2015) Factors Associated with Medication Nonadherence among Hypertensives in Ghana and Nigeria. Int J Hypertens 2015: 205716. Link: https://goo.gl/RoiR5N
Amira CO, Okubadejo NU (2007) Factors influencing noncompliance with anti-hypertensive drug therapy in Nigerians Niger Postgrad Med J 14: 325–329. Link: https://goo.gl/JstoBo
Odusola AO, Hendriks M, Schultsz C, Bolarinwa OA, Akande T, et al. (2014) Perceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study. BMC Health Serv Res 14: 624. Link: https://goo.gl/SqPMPx
Ho PM, Bryson CL, Rumsfeld JS (2009) Medication Adherence Its Importance in Cardiovascular Outcomes. Circulation 119: 3028-3035. Link: https://goo.gl/nWDFMm
Hugtenburg JG, Timmers L, Elders PJM, Vervloet M, van Dijk L (2013) Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence 7: 675–682. Link: https://goo.gl/vRMtFf
Jin J, Sklar GE, Oh VMS, Li SC (2008) Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag 4: 269–286. Link: https://goo.gl/DV5bVd
Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353: 487–497. Link: https://goo.gl/uEpXIv
Teferra S, Hanlon C, Beyero T, Jacobsson L, Shibre T (2013) Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers. BMC Psychiatry 13: 168. Link: https://goo.gl/Z0THgA
Nanaumi Y, Onda M, Mukai Y, Tanaka R, Tubota K, et al. (2012) Factors Related to Medication Adherence of Cognitively Impaired Patients in Community Pharmacies. Pharmacology & Pharmacy 3: 368-380. Link: https://goo.gl/Ve6HRc
Zigmond AS, Snaith RP (1983) The Hospital Anxiety And Depression Scale. Acta Psychiatr Scand67: 361-370. Link: https://goo.gl/mv7GVH
Mahoney FI, Barthel DW (1965) Functional Evaluation: The Barthel Index. Md State Med J 14: 61-65 Link: https://goo.gl/RXfVoG
Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24: 67–74. Link: https://goo.gl/4WbNkW
Oyati A, Orogade AA, Danbauchi SS, Azuh PC (2011) Awareness, treatment and control of hypertension among hypertensives in Zaria. Journal of Medicine in the Tropics 13: 139–144. Link: https://goo.gl/biev15
Ezeala-Adikaibe BA, Orjioke C, Ekenze OS, Ijoma U, Onodugo O, et al. (2015) Population based prevalence of high blood pressure among adults in an Urban Slum in Enugu, South East Nigeria. J Human Hypertens 30: 285-291. Link: https://goo.gl/WrgGy2
Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, et al. (2002) Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 24: 302-316. Link: https://goo.gl/4cNOId
Lemstra M, Alsabbagh MW (2014) Proportion and risk indicators of nonadherence to antihypertensive therapy: a metaanalysis. Patient Prefer and Adherence 8: 211–218. Link: https://goo.gl/yp0DPX
Zhang Y, Baik SH (2014) Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure. J Gen Intern Med 29: 602-607.
Al Mazrou S, Aljohani H, Aljibreen M, Alqahtani M, Alageel S (2016) Assessment of disability and medication adherence in Patients with Rheumatoid Arthitis (RA). J Appl Med Sci 5: 33-42. Link: https://goo.gl/ivSDs9
Grimsrud A, Stein DJ, Seedat S, Williams D, Myer L (2009) The Association between Hypertension and Depression and Anxiety Disorders: Results from a Nationally-Representative Sample of South African Adults. PLoS ONE 4: e5552. Link: https://goo.gl/mVxhhH
Wild MR, Engleman HM, Douglas NJ, Espie CA (2004) Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J 24: 461–465. Link: https://goo.gl/zgtRO2
Wai CT, Wong ML, Ng S, Cheok A, Tan MH, et al. (2005) Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis B. Aliment Pharmacol Ther 21: 1255–1262. Link: https://goo.gl/425R6k
Okuno J, Yanagi H, Tomura S, Oka M, Hara S, et al. (1999) Compliance and medication knowledge among elderly Japanese home-care recipients. Eur J Clin Pharmacol 55: 145–149. Link: https://goo.gl/Mi3V2g
Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, et al. (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA 288: 455–461. Link: https://goo.gl/H6pYfx
Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbas M (2005) Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Di 58: 152–158. Link: https://goo.gl/Q6bT7D
Senior V, Marteau TM, Weinman J (2004) Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions. Cardiovasc Drugs Ther 18: 475–481. Link: https://goo.gl/ooND4X
Osamor PE (2015) Social support and management of hypertension in south-west Nigeria Cardiovasc J Afr 26: 29–33. Link: https://goo.gl/YJOFCY
Spikmans FJ, Brug J, Doven MM, Kruizenga HM, Hofsteenge GH, et al. (2003) Why do diabetic patients not attend appointments with their dietitian? J Hum Nutr Diet 16: 151–158. Link: https://goo.gl/0vXW4M
Isezuo SA, Sabir AA, Ohwovorilole AE, Fasanmade AF (2011) Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. J Hum Hypertens 25: 224–230. Link: https://goo.gl/67Kk1q
Bovet P, Gervasoni JP, Mkamba M, Balampama M, Lengeler C, et al. (2008) Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based study. BMC Public Health 8: 407. Link: https://goo.gl/xIkI9e
Iihara N, Tsukamoto T, Morita S, Miyoshi C, Takabatake K, et al. (2004) Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication. J Clin Pharm Ther 29: 417–424. Link: https://goo.gl/qdRIAr
Kaplan RC, Bhalodkar NC, Brown EJ Jr, White J, Brown DL (2004) Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med 39: 1249-1255. Link: https://goo.gl/AqOopj
Ponnusankar S, Surulivelrajan M, Anandamoorthy N, Suresh B (2004) Assessment of impact of medication counseling on patients’ medication knowledge and compliance in an outpatient clinic in South India. Patient Educ Couns 54: 55–60. Link: https://goo.gl/6aERP6
Ghods AJ, Nasrollahzadeh D (2003) Noncompliance with immunosuppressive medications after renal transplantation. Exp Clin Transplant 1: 39–47. Link: https://goo.gl/gMPN2f
DiMatteo MR (2004) Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 23: 207–218. Link: https://goo.gl/QLbVQ0
Mathes T, Jaschinski T, Pieper D (2014) Adherence influencing factors—a systematic review of systematic reviews. Arch Public Health 72: 37-39. Link: https://goo.gl/3uRB9p
Salako BL, Ajose FA, Lawani L (2003) Blood pressure control in a population where antihypertensives are given free. East African Medical Journal 80: 529–531. Link: https://goo.gl/kWzmVU
Dusing R, Weisser B, Mengden T, Vetter H (1998) Changes in antihypertensive therapy-the role of adverse effects and compliance. Blood Press 7: 313–315. Link: https://goo.gl/cUSxQO